Enoxaparin - NDC Database (Page 7)
63323-655 May 01, 2019
Enoxaparin Sodium 120 mg/.8ml Subcutaneous Injection by Fresenius Kabi USA, LLC
Enoxaparin Sodium 120 mg/.8ml Subcutaneous Injection by Fresenius Kabi USA, LLC
68001-464 Oct 19, 2020
Enoxaparin Sodium 300 mg/3ml Intravenous; Subcutaneous Injection by Bluepoint Laboratories
Enoxaparin Sodium 300 mg/3ml Intravenous; Subcutaneous Injection by Bluepoint Laboratories
70710-1757 Apr 01, 2021
Enoxaparin Sodium 30 mg/.3ml Intravenous; Subcutaneous Injection, Solution by Zydus Pharmaceuticals (Usa) Inc.
Enoxaparin Sodium 30 mg/.3ml Intravenous; Subcutaneous Injection, Solution by Zydus Pharmaceuticals (Usa) Inc.
70710-1758 Apr 01, 2021
Enoxaparin Sodium 40 mg/.4ml Intravenous; Subcutaneous Injection, Solution by Zydus Pharmaceuticals (Usa) Inc.
Enoxaparin Sodium 40 mg/.4ml Intravenous; Subcutaneous Injection, Solution by Zydus Pharmaceuticals (Usa) Inc.
70710-1759 Apr 01, 2021
Enoxaparin Sodium 60 mg/.6ml Intravenous; Subcutaneous Injection, Solution by Zydus Pharmaceuticals (Usa) Inc.
Enoxaparin Sodium 60 mg/.6ml Intravenous; Subcutaneous Injection, Solution by Zydus Pharmaceuticals (Usa) Inc.
70710-1760 Apr 01, 2021
Enoxaparin Sodium 80 mg/.8ml Intravenous; Subcutaneous Injection, Solution by Zydus Pharmaceuticals (Usa) Inc.
Enoxaparin Sodium 80 mg/.8ml Intravenous; Subcutaneous Injection, Solution by Zydus Pharmaceuticals (Usa) Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.